Cancer Letters
Volume 230, Issue 1 , Pages 25-32, 8 December 2005

Enhancement by acrylamide of N-methyl-N-nitrosourea-induced rat mammary tumor development—possible application for a model to detect co-modifiers of carcinogenesis

Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-Ku, Tokyo 158-8501, Japan

Received 17 August 2004; received in revised form 26 November 2004; accepted 15 December 2004.

Abstract 

Acrylamide (AA) has recently been reported to be spontaneously formed in fried and baked foods with various concentrations. Although carcinogenicity in humans is as yet equivocal, numerous positive genotoxicity data in vitro and in vivo and results of rat long-term carcinogenicity studies demonstrating tumor induction at multiple sites, like the mammary gland, thyroid and testes, suggest the risk with dietary exposure may not be negligible. In the present study, to establish a medium-term carcinogenesis model for screening of agents with the potential to modify AA effects on the mammary gland and thyroid, we pretreated rats with 7,12-dimethylbenz(a)anthracene (DMBA), in combination with N-bis(2-hydroxypropyl)nitrosamine (DHPN), or N-methyl-N-nitrosourea (MNU) alone and then administered AA at 20 and 40ppm in the drinking water for 30 weeks. The incidence and multiplicity of mammary tumors were increased at the high dose (P<0.05) in MNU— but not DMBA+DHPN-treated rats. No thyroid tumors were induced in any case. The results indicate that the MNU model is suitable for detection of modifiers of AA actions.

Keywords: Acrylamide, Mammary carcinogenesis, Rat, N-methyl-N-nitrosourea, 7,12-Dimethylbenz(a)anthracene, Medium-term model

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(04)00996-6

doi:10.1016/j.canlet.2004.12.019

Cancer Letters
Volume 230, Issue 1 , Pages 25-32, 8 December 2005